Influence of physiological variables on the in vitro drug-release behavior of a polysaccharide matrix controlled-release system

Drug Development and Industrial Pharmacy

Volumn 29, Issue 1, 2003, Pages 19-29

  Mu, Xiaohong ^a,b   Tobyn, Michael J ^a   Staniforth, John N ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Locust bean gum; Matrix; Polysaccharide; Type III dissolution; Xanthan gum

Indexed keywords

ALGAROBA; GLUCOSE; POLYSACCHARIDE; PROPRANOLOL; XANTHAN;

ARTICLE; CONTROLLED RELEASE FORMULATION; DIET RESTRICTION; DRUG DETERMINATION; DRUG GRANULE; DRUG RELEASE; DRUG SOLUBILITY; FEEDING; GASTROINTESTINAL SECRETION; IONIC STRENGTH; PH; TABLET HARDNESS; TABLET MANUFACTURE; TABLET POROSITY;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIGESTIVE SYSTEM; DRUG COMPOUNDING; HARDNESS; HYDROGEN-ION CONCENTRATION; OSMOLAR CONCENTRATION; POLYSACCHARIDES; POROSITY; POWDERS; PROPRANOLOL; SOLUBILITY; TABLETS; TIME FACTORS; WATER;

EID: 0037278522     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120016680     Document Type: Article

References (38)

1. Alderman, D.A. Review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage form. Int. J. Pharm. Technol. Prod. Mfr. 1984, 5, 1-9.
2. Melia, C.D. Hydrophilic matrix sustained-release systems based on polysaccharide carriers. Crit. Rev. Ther. Drug Carrier Sys. 1991, 8 (4), 395-421.
3. Staniforth, J.N.; Baichwal, A.R. Synergistically interacting heterodisperse polysaccharides. In Polymer Delivery Systems, ACS Symposium Series; American Chemical Society: USA, 1993; Vol. 520, 327-350.
4. Harland, R.S.; Gazzaniga, A.; Sangalli, M.E.; Colombo, P.; Peppas, N.A. Drug/polymer matrix swelling and dissolution. Pharm. Res. 1988, 5, 488-494.
5. Colombo, P.; Bettini, R.; Santi, P.; De Ascentiis, A.; Peppas, N.A. Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport. J. Control Rel. 1996, 39, 231-237.
6. Talukdar, M.M.; Kinget, R. Swelling and drug release behavior of xanthan gum matrix tablets. Int. J. Pharm. 1995, 120, 63-72.
7. Colombo, P.; Bettini, R.; Massimo, G.; Catellani, P.L.; Santi, P.; Peppas, N.A. Drug diffusion front movement is important in drug release control from swellable matrix tablets. J. Pharm. Sci. 1995, 84, 991-997.
8. Bettini, R.; Catellani, P.L.; Santi, P.; Massimo, G.; Peppas, N.A.; Colombo, P. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J. Control Rel. 2001, 70 (3), 383-391.
9. Heng, P.W.S.; Chan, L.W.; Easterbrook, M.G.; Li, X.M. Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J. Control Rel. 2001, 76 (1-2), 39-49.
10. Bonferoni, M.C.; Rossi, S.; Ferrari, F.; Bertoni, M.; Caramella, C. A study of three hydroxypropyl cellulose substitution types: effect of particle size and shape on hydrophilic matrix performance. STP Pharma Sci. 1996, 6 (4), 277-284.
11. Kim, H.; Fassihi, R. Application of binary system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci. 1996, 86, 323-328.
12. Ford, J.L.; Rubinstein, H.; McCaul, F.; Hogan, J.E.; Edgar, P.J. Importance of drug type, tablet shape, and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Int. J. Pharm. 1987, 40, 223-234.
13. Gupta, V.K.; Hariharan, M.; Wheatley, T.A.; Price, J.C. Controlled-release tablets from carrageenans: effects of formulation, storage, and dissolution factors. Eur. J. Pharm. Biopharm. 2001, 51 (3), 241-248.
14. Victoria Velasco, M.; Ford, J.L.; Rowe, P.; Rajabi-Siahboomi, A.R. Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J. Control Rel. 1999, 57, 75-85.
15. Hodsdon, A.C.; Mitchell, J.R.; Davies, M.C.; Melia, C.D. Structure and behavior in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices. J. Control Rel. 1995, 33, 143-152.
16. Johnson, J.L.; Holinej, J.; Williams, M.D. Influence of ionic strength on matrix integrity and drug release from hydroxypropyl cellulose compacts. Int. J. Pharm. 1993, 90, 151-159.
17. Bonferoni, M.C.; Rossi, S.; Ferrari, F.; Bertoni, M.; Caramella, C. Influence of medium on dissolution-erosion behavior of Na carboxymethylcellulose and on viscoelastic properties of gels. Int. J. Pharm. 1995, 117 (1), 41-48.
18. Welling, P.G. Effects of food on drug absorption. Annu. Rev. Nutr. 1996, 16, 383-415.
19. Oosterhuis, B.; Jonkman, J.H.G. Pharmacokinetics studies in healthy volunteers in the context of in vitro/in vivo correlations. Eur. J. Drug Metab. Pharmacokinet. 1993, 18, 19-30.
20. Wilson, C.G.; Washington, N. Physiological Pharmaceutics; Ellis Harwood Ltd.: England, 1989; 47-108.
21. Abrahamsson, B.; Alpsten, M.; Bake, B.; Jonsson, U.E.; Eriksson-Lepkowska, M.; Larsson, A. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. J. Control Rel. 1998, 52 (3), 301-310.
22. Gai, M.N.; Isla, A.; Andonaegui, M.T.; Thielemann, A.M.; Seitz, C. Evaluation of the effect of 3 different diets on the Bioavailability of 2 sustained release theophylline matrix tablets. Int. J. Clin. Pharmacol. Ther. 1997, 35 (12), 565-571.
23. Abrahamsson, B.; Roos, K.; Sjogren, J. Investigation of prandial effects on hydrophilic matrix tablets. Drug Dev. Ind. Pharm. 1999, 25, 765-771.
24. Morris, V.J. Bacterial polysaccharides. In Food Polysaccharides and Their Applications; Stephen, A.M., Ed.; Marcel Dekker Inc.: New York, 1995; 341-375.
25. Williams, P.A.; Phillips, G.O. Interactions in mixed polysaccharide systems. In Food Polysaccharides and Their Applications; Stephen, A.M., Ed.; Marcel Dekker Inc.: New York, 1995; 478-493.
26. Tako, M. Synergistic interaction between deacetylated xanthan and galactomannan. J. Carbohydr. Chem. 1991, 10, 619-633.
27. Charman, W.N.; Porter, C.J.H.; Mithani, S.; Dressman, J.B. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci. 1997, 86, 269-282.
28. Staniforth, J.N. Powder flow. In Pharmaceutics - The Science of Dosage Form Design; Aulton, M.E., Ed.; Churchill Livingstone: London, 1988; 612-613.
29. The United States Pharmacopoeia; USPC, Inc.: 1995; 1330.
30. Peppas, N.A. Analysis of fickian and non-fickian drug release polymers. Pharm. Acta. Helv. 1985, 60, 110-111.
31. Mockel, J.E.; Lippold, B.C. Zero-order drug release from hydrocolloid matrices. Pharm. Res. 1993, 10, 1066-1070.
32. Chang, C.-M.; Bodmeier, R. Effect of dissolution media and additives on the drug release from cubic phase delivery systems. J. Control. Rel. 1997, 46, 215-222.
33. Talukdar, M.M.; Plaizier-Vercammen, J. Evaluation of xanthan gum as a hydrophilic matrix for controlled-release dosage form preparations. Drug Dev. Ind. Pharm. 1993, 19, 1037-1046.
34. Tobyn, M.J.; Maher, J.; Challinor, C.L.; Staniforth, J.-N. Investigation of the interactions between a novel controlled release matrix and model compounds using ESR. J. Control Rel. 1996, 40, 147-155.
35. Zhan, D.F.; Ridout, M.J.; Brownsey, G.J.; Morris, V.J. Xanthan-locust bean gum interactions and gelation. Carbohydr. Polym. 1993, 21, 53-58.
36. Tako, M.; Asato, A.; Nakamura, S. Rheological aspects of the intermolecular interaction between xanthan and locust bean gum in aqueous media. Agric. Biol. Chem. 1984, 48, 2995-3000.
37. Morris, E.R.; Foster, T.J. Role of conformation in synergistic interactions of xanthan. Carbohydr. Polym. 1994, 23, 133-135.
38. Williams, P.A.; Day, D.H.; Langdon, M.J.; Philips, G.O.; Nishinari, K. Synergistic interaction of xanthan gum with glucomannans and galactomannans. Food Hydrocoll. 1991, 4, 489.